Expression of apoptosis repressor with caspase recruitment domain (ARC) in familial adenomatous polyposis (FAP) adenomas and its correlation with DNA mismatch repair proteins, p53, Bcl-2, COX-2 and beta-catenin
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-811X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Expression of apoptosis repressor with caspase recruitment domain (ARC) in familial adenomatous polyposis (FAP) adenomas and its correlation with DNA mismatch repair proteins, p53, Bcl-2, COX-2 and beta-catenin ; volume:19 ; number:1 ; day:12 ; month:2 ; year:2021 ; pages:1-11 ; date:12.2021
Cell communication and signaling ; 19, Heft 1 (12.2.2021), 1-11, 12.2021
- Urheber
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12964-020-00702-x
- URN
-
urn:nbn:de:101:1-2021040308511270589397
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Roser, Christoph
- Tóth, Csaba
- Renner, Marcus
- Herpel, Esther
- Schirmacher, Peter
- SpringerLink (Online service)
Ähnliche Objekte (12)
Pathogenesis of human hepatocellular carcinoma
Pemigatinib : erste zielgerichtete Zweitlinientherapie beim Cholangiokarzinom mit FGFR2-Fusion/Rearrangement
Molecular diagnostics of hepatobiliary and pancreatic neoplasias
Opposite effects of tissue inhibitor of metalloproteinases-1 (TIMP-1) over-expression and knockdown on colorectal liver metastases
Gene Expression Profiling in Familial Adenomatous Polyposis Adenomas and Desmoid Disease
Integrated genotype–phenotype analysis of familial adenomatous polyposis-associated hepatocellular adenomas
Endoscopic Approach to Duodenal Adenomas in Familial Adenomatous Polyposis: A Retrospective Cohort
Chromosome 9p copy number gains involving PD-L1 are associated with a specific proliferation and immune-modulating gene expression program active across major cancer types
The role of apoptosis repressor with a CARD domain (ARC) in the therapeutic resistance of renal cell carcinoma (RCC): the crucial role of ARC in the inhibition of extrinsic and intrinsic apoptotic signalling
Surveillance of duodenal adenomas in familial adenomatous polyposis patients: medical objectives and technical requirements
Treatment decisions, clinical outcomes, and pharmacoeconomics in the treatment of patients with EGFR mutated stage III/IV NSCLC in Germany: an observational study
Gastric adenomas in familial adenomatous polyposis are common, but subtle, and have a benign course
Pathogenesis of human hepatocellular carcinoma
Pemigatinib : erste zielgerichtete Zweitlinientherapie beim Cholangiokarzinom mit FGFR2-Fusion/Rearrangement
Molecular diagnostics of hepatobiliary and pancreatic neoplasias
Opposite effects of tissue inhibitor of metalloproteinases-1 (TIMP-1) over-expression and knockdown on colorectal liver metastases
Gene Expression Profiling in Familial Adenomatous Polyposis Adenomas and Desmoid Disease
Integrated genotype–phenotype analysis of familial adenomatous polyposis-associated hepatocellular adenomas
Endoscopic Approach to Duodenal Adenomas in Familial Adenomatous Polyposis: A Retrospective Cohort
Chromosome 9p copy number gains involving PD-L1 are associated with a specific proliferation and immune-modulating gene expression program active across major cancer types
The role of apoptosis repressor with a CARD domain (ARC) in the therapeutic resistance of renal cell carcinoma (RCC): the crucial role of ARC in the inhibition of extrinsic and intrinsic apoptotic signalling
Surveillance of duodenal adenomas in familial adenomatous polyposis patients: medical objectives and technical requirements
Treatment decisions, clinical outcomes, and pharmacoeconomics in the treatment of patients with EGFR mutated stage III/IV NSCLC in Germany: an observational study
Gastric adenomas in familial adenomatous polyposis are common, but subtle, and have a benign course
Pathogenesis of human hepatocellular carcinoma
Pemigatinib : erste zielgerichtete Zweitlinientherapie beim Cholangiokarzinom mit FGFR2-Fusion/Rearrangement
Molecular diagnostics of hepatobiliary and pancreatic neoplasias
Opposite effects of tissue inhibitor of metalloproteinases-1 (TIMP-1) over-expression and knockdown on colorectal liver metastases
Gene Expression Profiling in Familial Adenomatous Polyposis Adenomas and Desmoid Disease
Integrated genotype–phenotype analysis of familial adenomatous polyposis-associated hepatocellular adenomas
Endoscopic Approach to Duodenal Adenomas in Familial Adenomatous Polyposis: A Retrospective Cohort
Chromosome 9p copy number gains involving PD-L1 are associated with a specific proliferation and immune-modulating gene expression program active across major cancer types
The role of apoptosis repressor with a CARD domain (ARC) in the therapeutic resistance of renal cell carcinoma (RCC): the crucial role of ARC in the inhibition of extrinsic and intrinsic apoptotic signalling
Surveillance of duodenal adenomas in familial adenomatous polyposis patients: medical objectives and technical requirements
Treatment decisions, clinical outcomes, and pharmacoeconomics in the treatment of patients with EGFR mutated stage III/IV NSCLC in Germany: an observational study